Up +28% ahead of Q2 earnings, this software giant still has 49%+ upside

The article spotlights Salesforce ahead of its Q2 results (due Wednesday) amid a public-sector/AI momentum wave, citing a recent +28.14% rally since July. It claims ProPicks AI fair value of $310.64 vs current price (up to +48.5% upside) and points to Q1 FY2027 revenue of $11.1B (+13% YoY) with earnings ~24% above forecasts, supported by a $25B share buyback program. Overall framing is value/catalyst-driven with investors positioned for the next earnings cycle, but the piece is promotional/positioning-focused rather than reporting new macro moves.

Analysis

The bigger signal here is not the stock-pick marketing; it is that the market is still paying up for companies that can prove AI or public-sector monetization with a visible path to recurring cash flow. For CRM, the federal narrative matters less as a one-off revenue bump than as a credibility upgrade that can expand deal size and retention over 6-18 months, but the near-term risk is margin drag from implementation, security, and compliance work before revenue fully catches up. That makes the post-earnings reaction more about bookings quality and cRPO than headline contract announcements.

MRVL is the cleaner earnings catalyst because custom silicon can re-rate the entire supply chain: if hyperscaler-designed ASICs keep taking share, it supports GOOGL’s cloud economics while pressuring merchant accelerator growth expectations at NVDA and, to a lesser extent, AMD over the next 1-3 quarters. The second-order winners are advanced packaging and test suppliers, while the loser is the assumption that every AI dollar must flow through general-purpose GPUs. If management cannot quantify how much of the Google relationship converts to 2025 revenue, the stock can easily give back its recent momentum even on a good print.

Contrarianly, the consensus is underestimating how much of these moves are already priced: the recent run-ups mean the bar is now set by guide, not by narrative. The promo-style basket of recent winners looks more like a momentum screen than a durable alpha engine, so this is a market where disappointment risk is asymmetric. Falsifiers are simple: CRM needs accelerating remaining performance obligations and stable or improving operating margin; MRVL needs explicit revenue ramp from custom silicon and no sign of hyperscaler capex digestion.

Key Decisions for Investors

• CRM: stay constructive only on a post-earnings pullback or confirmation that cRPO/bookings are accelerating; if guide is merely in-line, fade the move rather than chase. Time horizon: 1-3 months; upside comes from multiple support plus buyback, downside is a de-rating if the federal wins are not translating into durable pipeline.
• MRVL: small tactical long only if earnings commentary quantifies Google-related revenue conversion; otherwise wait. Use a call spread into the print if implied move is cheap, but keep size modest because the stock is vulnerable to 'design-win but no timing' disappointment.
• Hedge AI-semiconductor exposure with a short NVDA / long MRVL relative-value trade into earnings if you believe custom silicon share gains are becoming the marginal driver. Best held over 1-3 quarters; thesis breaks if hyperscaler capex broadens back toward merchant GPUs.
• If already long large-cap software, pair CRM long against a weaker software beta basket or XSW short on any weakness, since CRM has a clearer buyback floor and better visibility than the average SaaS name. Reassess if CRM fails to hold its post-earnings gap within 2-3 sessions.
• Treat BTU/MATV/METC/HAE/IT as momentum-only exposures, not fundamental longs at current levels; use strength to trim if risk appetite rolls over. These names are more likely to mean-revert than continue compounding without fresh earnings revisions.